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A 35-year-old male patient with Down’ s syndrome received radical inguinal orchitectomy for left
testicular tumor in 2006. Histological examination revealed a typical seminoma. 18 months after the
operation, we found a metastasis in the right retroperitoneum lymph node. He received adjuvant
chemotherapy (bleomycin, etoposide, and cisplatin : BEP). After 3 cycles of chemothrapy, the tumor
disappeared. There is no obvious reccurence sign and general condition is good after chemotherapy. As
we treated a relapse of seminoma in Down’s syndrome successfully, we report this case and review 41 cases in
Japanese literatures.
(Hinyokika Kiyo 56 : 397-401, 2010)





























入院時現症 : 意識清明，身長 154.7 cm，体重 58.3
kg，BMI 24.4，血圧 116/77 mmHg，脈拍 68 bpm，体
温 36.7°C，神経学的に異常を認めず，頭頸部特徴的
顔貌，胸部 ; 正常肺胞音，心音 ; 純，腹部 ; 平坦，
泌尿紀要 56 : 397-401，2010年 397
軟，CVA 叩打痛なし，陰嚢 ; 右触知せず，左腫大な
し，四肢末梢に浮腫・紫斑を認めず，血液 ; 検血 ;
WBC 5,500/μl，RBC 4.47×104/μl，Hb 12.9 g/dl，Plt
313×104/μl ．生化学 ; TP 7.9 g/dl，Alb 3.9 g/dl，T-
Bil 0. 5 g/dl，AST 22 IU/l，ALT 16 IU/l，ALP 275
IU/l，CHE 338 U，CRP 0.17 mg/dl，Cre 1.06 g/dl，
BUN 16 g/dl，Ca 8. 8 mg/dl，Na 141 mEq/l，K 4. 3
mEq/l，Cl 103 mEq/l．腫瘍マーカー ; LDH 189 IU/l
(97∼207），AFP 9.0 ng/ml (0∼13.4），βHCG ＜0.1
ng/ml (＜0.1)．
治療経過 : 再発は，CT 上後腹膜リンパ節のみであ
り，BEP を合計 3コースの予定にて化学療法を開始
した．後腹膜リンパ節再発巣は1・ 2 コース目で PR
(partial response）， 3 コース目で CR (complete re-








あった間質性肺炎のマーカー ; SP-D が 177 ng/ml (＜
110) と上昇を認め，さらに CT でも間質性肺炎を疑
わせる所見を認めたため (Fig. 2），プレドニンの内服
を開始した．その後は除々に改善を認め，SP-D も




















b) after 2nd course of the chemo therapy
泌56,11,10-2c
c) after 3rd course
泌56,07,11-2d
d) now
Fig. 1. Computed tomography (CT) demonstrates left paraaortic and left iliac nodal recurrence of
testicular tumor on adimission. And the recurrence was disappeared after chemotherapy.




































b) after 1st course of the chemo therapy
泌56,11,10-2c
c) after 2nd course
泌56,07,11-2d
d) after 3rd course
泌56,07,11-2e
e) now
Fig. 2. After second course of the chemo therapy, subpleural effusion was appeared. The effusion
became worse after the third course of the chemotherapy. There is no effusion now.







Table 1. Cases of Down’s syndrome associated with testicular tumor
No. Author Year Age Side Histology Therapy Prognosis
1 Sakashita, et al. 1980 1 L york sac Ox 10 y alive
2 Tomoishi, et al. 1983 31 L seminoma Ox＋Rd＋lymphadenectomy 7 m alive
3 Kawahara, et al. 1984 37 B seminoma : L Ox＋VAB6*3 *
** ** ** ** ** seminoma＋chrio : R ** **
4 Kamidomo, et al. 1985 41 R seminoma partial resectomy 2 w died
5 Sasagawa, et al. 1986 35 R seminoma Ox *
6 Suga, et al. 1988 24 R embryonal＋york sac Ox 8 m died
7 Ueno, et al. 1992 27 L seminoma Ox＋Rd 14 m alive
8 Nishida, et al. 1993 43 L seminoma Ox＋Rd 5 m alive
9 Nishida, et al. 1993 30 R seminoma Ox＋Rd 41 m alive
10 Funaki, et al. 1993 21 L seminoma Ox *
# Funaki, et al. 1993 24 R # # #
11 Yamamoto, et al. 1994 21 B seminoma : R Ox＋Ch 1 y alive
** ** ** ** ** seminoma : L ** **
12 Hashimoto, et al. 1995 17 R embryonal Ox＋BEP2 2 y alive
13 Nakamura, et al. 1996 20 R embryonal＋york sac＋chorio Ox 1 y alive
14 Sekiguchi, et al. 1996 34 R seminoma non 1 y died
15 Uchikoba, et al. 1998 20 L seminoma Ox＋Rd 2 y alive
16 Kishimoto, et al. 1997 27 R seminoma Ox 14 m alive
17 Tuzaki, et al. 1998 34 R seminoma Ox *
18 Machida, et al. 1998 34 L seminoma Ox *
19 Ichiyanagi, et al. 1998 30 R seminoma Ox 8 m alive
20 Higashi, et al. 1999 40 R seminoma Ox (2 m alive)
21 Karai, et al. 1999 27 L seminoma Ox 5 m alive
22 Miki, et al. 1999 42 L seminoma Ox 2 y died
23 Ashizawa, et al. 2000 28 L seminoma Ox 5 m alive
24 Yanagisawa, et al. 2000 32 L seminoma Ox 7 m alive
25 Yamada, et al. 2000 32 B seminoma : L Ox 43 m alive
** ** ** ** ** seminoma : R Ox＋Rd 7 m alive
26 Matsumoto, et al. 2000 38 L seminoma Ox 6 m alive
27 Hayashi, et al. 2000 40 R seminoma Ox＋Rd 10 m alive
28 Tihara, et al. 2000 34 R embryonal Ox＋BEP3 (5 m alive)
29 Kita, et al. 2002 35 R seminoma Ox＋BEP3 9 m alive
30 Imajo, et al. 2002 32 L seminoma Ox 10 m alive
31 Yoshida, et al. 2003 33 B embrional＋seminoma : L Ox＋PVB2 12 y alive
** ** ** ** ** seminoma : R Ox *
32 Yonemura, et al. 2003 31 L chorio Ox＋BEP3＋VIP3＋Etoposide * died
33 Sasaki, et al. 2004 27 L embryonal＋immature teratoma Ox＋BEP3＋TIP *
34 Inoue, et al. 2004 53 L seminoma Ox 6 m alive
35 Kadono, et al. 2005 32 L seminoma Ox (8 m alive)
36 Suzuki, et al. 2005 33 L seminoma Ox 4 y alive
37 Tsukamoto, et al. 2006 29 R seminoma Ox＋BEP2＋EP1 *
38 Ohara, et al. 2006 28 L seminoma Ox *
39 Kuroda, et al. 2007 20 L embryonal＋yolk sac Ox＋Ch 7 m alive
40 Miyamoto, et al. 2008 31 R seminoma Ox＋BEP2 31 m died
41 Present case 2009 37 L seminoma Ox＋BEP2＋EP1 3 y alive
Ox : Orchitectomy, Rd : Radiation, Ch : chemotherapy. chorio : choriocarcinoma, yolk sac : yolk sac tumor, embryonal : embryonal
carcinoma. * : No data, # : same as No. 6 case.
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